The strategic value of philanthropic organisations in public-private partnerships - the example of the Innovative Health Initiative Philanthropic organisations are contributing significantly to IHI call 11. Here, they explain why IHI is well placed to enable public, private and philanthropic partners to work together strategically...

🤝 #Philanthropic organisations are contributing significantly to IHI call 11. In the last #IHISummerOfScience story, they explain why IHI is well placed to enable public, private and philanthropic partners to work together strategically
👉 europa.eu/!QfjyyX

Going green: meet the projects boosting the environmental performance of the health sector IMI and IHI projects are tackling the environmental impacts of the sector, from the use of water, energy and raw materials to pollution and waste management.

🏞️ IMI/IHI projects are addressing the environmental impacts of the health sector, advancing clean medicines manufacture, environmental risk assessments for drugs & the sustainability of single-use medical devices + packaging
👉 europa.eu/!hQw8jp
#IHITransformingHealth #IHISummerOfScience #HorizonEU

Promoting vaccination amongst the elderly with VITAL’s new tools The VITAL project published an educational platform as well as a toolbox to boost vaccination uptake amongst older people.

👴 #Vaccines are key to helping older people stay healthy, but vaccination rates are lower than they should be.
👩‍⚕️ IMI project VITAL has delivered tools to help boost vaccination among the elderly.
👉 europa.eu/!GJq8T8
#IHITransformingHealth #IHISummerOfScience #HorizonEU #VaccinesWork

New paper in Nature Reviews Drug Discovery highlights how to maximise the regulatory impact of consortium-based projects The paper, by authors from IHI and the Critical Path Institute, highlights the importance of a structured, strategic approach to regulatory issues from the beginning.

🏛️ Helping projects achieve regulatory impact is the topic of today’s #IHISummerOfScience story. Writing in @natrevdrugdiscov.nature.com, authors from IHI and @cpathinstitute.bsky.social offer their advice to consortia

👉 europa.eu/!nKyFyQ

#IHITransformingHealth #HorizonEU #RegulatoryScience

IHI and IMI: Laying the foundations of the European Health Data Space IMI and IHI projects provide a neutral platform where public and private datasets can be shared within a secure environment. This means that IHI and IMI projects are the perfect testing ground for ful...

🔒 IMI/IHI projects provide a neutral platform where #HealthData from public/private sources can be shared within a secure environment, making them a perfect testing ground for implementing the #EuropeanHealthDataSpace
👉 europa.eu/!BbTPDt
#EHDS #IHITransformingHealth #IHISummerOfScience #HorizonEU

Making Europe more attractive for conducting clinical trials IHI and IMI projects are enhancing the environment in Europe for conducting clinical trials by connecting relevant sites and experts, investigating new trial designs and protocols, and developing tool...

🌍 The #DraghiReport on EU #competitiveness highlights the importance of making Europe more attractive for #ClinicalTrials.
🏥 As today's #IHISummerOfScience story shows, IMI and IHI projects are contributing to this effort in multiple ways!
👉 europa.eu/!vm9GyT
#IHITransformingHealth #HorizonEU

New immunotracers indicate whether immunotherapy will work New tools developed by the Immune-Image project can indicate the presence of cells that inhibit immunotherapy.

🏥 #Immunotherapy has revolutionised #cancer treatment, but it doesn’t work for everyone
🚦 IMI project Immune-Image devised a test based on #imaging to determine if a patient will respond well to immunotherapy or not
👉 europa.eu/!BrYW79
#IHITransformingHealth #IHISummerOfScience #HorizonEU

Real-world results: Mobilise-D algorithms enter the market The algorithms that translate walking patterns into indicators of health have been integrated by private companies EMPATICA, Clario, McRoberts and Actigraph into their products.

🚶‍♂️The way you walk offers clues to your health
📉 IMI project MOBILISE-D's algorithms translate walking patterns into indicators to track changes in disease status
✅ Companies are using the public algorithms in their products
👉 europa.eu/!GFFHYt
#IHITransformingHealth #IHISummerOfScience #HorizonEU

Directing the power of AI towards finding compounds to combat antimicrobial resistance The COMBINE project trained an AI model to improve the selection of compounds that can fight multi-drug resistant bacteria – a newly published peer-reviewed paper outlines how they did it.

🧫 Developing new #antibiotics is extremely difficult
👩‍💻 IMI project COMBINE developed an #ArtificialIntelligence model to improve selection of compounds that can fight multi-drug resistant bugs
👉 europa.eu/!MpcQNr
#IHITransformingHealth #HorizonEU #IHISummerOfScience @amr-accelerator.bsky.social

A book lying open on a pebbly beach, with the sea in the background. Image by Lucky Team Studio via Shutterstock.

📚 It’s a long weekend here in Belgium, so today’s #IHISummerOfScience offering is a #longread – our 2024 highlights brochure is packed with information and project successes!
👉 europa.eu/!WFhqyC
#IHITransformingHealth #IHISummerOfScience #HorizonEU

Preparing for the next pandemic with the CARE project After the outbreak of the COVID-19 pandemic in 2020, several projects including the CARE consortium were funded by IMI to investigate pandemic preparedness. We sat down for a chat with Yves Lévy, the ...

😷 IMI #COVID19 project CARE helped advance our understanding of the SARS-CoV-2 virus and laid the groundwork for improving #preparedness for future #pandemics.
👉 europa.eu/!7vRqqQ
#IHITransformingHealth #IHISummerOfScience #HorizonEU

New depression trial will use EU-PEARL study designs The first Europe-wide platform study on the safety and efficacy of treatments for depression will use study designs from the IMI EU-PEARL project.

📃 Earlier this year, a consortium announced plans to use a master protocol developed by our EU-PEARL project in the first Europe-wide platform study on the safety & efficacy of treatments for #depression
👉 europa.eu/!4pNYJq
#IHITransformingHealth #IHISummerOfScience #HorizonEU #ClinicalTrials

Predicting obesity complications – in those who are not obese The IMI Sophia project identified five subgroups of people whose risk for obesity complications is not aligned with their body mass index (BMI).

📊 IMI project SOPHIA used machine learning to uncover 5 subgroups of people whose risk for #obesity complications and #BMI are not aligned. This could help identify more people at risk of these complications.
👉 europa.eu/!n6jJd6
#IHITransformingHealth #IHISummerOfScience #HorizonEU

MACUSTAR receives third nod of approval from regulators The European Medicines Agency issued a third letter of support for the development of new biomarkers and clinical endpoints for a condition that blurs vision and can lead to blindness.

👁️ Age-related macular degeneration is a leading cause of #blindness
📉 The EMA has issued letters of support for MACUSTAR's work on tools to accurately detect changes in eyesight & measures to assess how well a treatment works
👉 europa.eu/!3rB3nq
#IHITransformingHealth #IHISummerOfScience #HorizonEU

‘Ahead of the curve’ – new study confirms relevance and value of IHI A wide-ranging evaluation of IMI2 and IHI highlights the ability of the programmes to drive innovation and have an impact on patient care and quality of life.

📚 Published last autumn, the official evaluation of IMI2 and IHI highlighted the ability of the programmes to drive innovation and have an impact on patient care and quality of life.
Find out more 👉 europa.eu/!wGbNgT
#IHITransformingHealth #IHISummerOfScience #HorizonEU

IHI and IMI projects are closing the gender gap in health Up until fairly recently, women were largely left out of clinical trials and there are still gaps in what we know about women’s health. IHI and IMI projects are investigating safe medicine use in preg...

👭 There are still big gaps in what we know about women’s health.

🤸‍♀️ IHI and IMI projects are investigating safe medicine use in pregnancy as well as in cancers and autoimmune diseases that primarily affect women.

👉 europa.eu/!mkNwyk

#IHITransformingHealth #IHISummerOfScience #HorizonEU

How to fight AMR: public-private partnerships lead the way The AMR Accelerator is a proven model for the development of new antimicrobial drugs, experts say

💊 IMI’s AMR Accelerator is a model for how public-private partnerships (PPPs) can make an impact on the complex world of #antibiotic research and development, experts say.

Find out more 👉 europa.eu/!wcRPPx

#IHITransformingHealth #IHISummerOfScience #HorizonEU #AntimicrobialResistance

New paper highlights strong IMI/IHI contribution to paediatric research IMI and IHI projects are boosting paediatric research and development, writes IHI’s Nathalie Seigneuret in Frontiers in Medicine.

👶 All too often, children are treated with medicines and devices designed for adults.

IMI and IHI projects are turning this around, advancing #paediatric research and delivering results that are making a difference

👉 europa.eu/!TTkHhJ

#IHITransformingHealth #HorizonEU #IHISummerOfScience

A person lying in a hammock under a tree on a hillside, reading a book. Image by New Africa via Shutterstock.

🌞 Summer’s here, and if you’re looking for something to read on the beach / up the mountain / on the terrace of a café, you’re in the right place!
📚 Starting next week, every day we’ll share an IHI news story from the past year with the hashtag #IHISummerOfScience
#IHITransformingHealth #HorizonEU